G 224 (Lithium Carbonate Extended Release 450 mg)
Pill with imprint G 224 is Yellow, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by Glenmark Generics Inc..
Lithium is used in the treatment of bipolar disorder; mania; schizoaffective disorder and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 224
Lithium Carbonate Extended Release
- Imprint
- G 224
- Strength
- 450 mg
- Color
- Yellow
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimanic agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Generics Inc.
- National Drug Code (NDC)
- 68462-0224
- Inactive Ingredients
-
sodium alginate,
microcrystalline cellulose,
ferric oxide yellow,
isopropyl alcohol,
magnesium silicate,
magnesium stearate,
sodium starch glycolate type A potato,
hypromelloses
Note: Inactive ingredients may vary.
Related Images for "G 224"
More about lithium
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 397 Reviews
- Drug class: antimanic agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Lithium (Advanced Reading)
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
- Other brands
- Eskalith, Lithobid, Eskalith-CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.